CX Institutional - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,173 filers reported holding NOVARTIS A G in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
CX Institutional ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2024$1,094,196
+10.9%
10,278
+0.7%
0.05%
+6.2%
Q1 2024$986,839
-4.7%
10,202
-0.5%
0.05%
-12.7%
Q4 2023$1,035,447
-0.9%
10,2550.0%0.06%
-5.2%
Q3 2023$1,044,574
+0.9%
10,2550.0%0.06%
+7.4%
Q2 2023$1,034,832
+8.1%
10,255
-0.9%
0.05%
+5.9%
Q1 2023$957,397
+3.4%
10,348
+1.4%
0.05%
-8.9%
Q4 2022$925,525
+19.4%
10,2020.0%0.06%
+3.7%
Q3 2022$775,000
-10.1%
10,2020.0%0.05%
-16.9%
Q2 2022$862,000
-3.7%
10,2020.0%0.06%
-9.7%
Q1 2022$895,000
+15.9%
10,202
+15.6%
0.07%
+18.0%
Q4 2021$772,000
-7.4%
8,827
-13.5%
0.06%
-10.3%
Q3 2021$834,000
-10.4%
10,2020.0%0.07%
-10.5%
Q2 2021$931,000
+6.8%
10,2020.0%0.08%
-2.6%
Q1 2021$872,000
-9.4%
10,2020.0%0.08%
-16.1%
Q4 2020$963,000
+8.4%
10,202
-0.1%
0.09%
-3.1%
Q3 2020$888,000
-0.8%
10,215
-0.3%
0.10%
-18.6%
Q2 2020$895,000
+7.7%
10,246
+1.6%
0.12%
-13.2%
Q1 2020$831,000
-12.9%
10,0800.0%0.14%
-18.1%
Q4 2019$954,000
+8.8%
10,080
-0.2%
0.17%
+16.9%
Q3 2019$877,000
-5.2%
10,096
-0.3%
0.14%
-3.4%
Q2 2019$925,000
-7.4%
10,125
-2.6%
0.15%
-16.5%
Q1 2019$999,000
+15.6%
10,393
+3.2%
0.18%
-3.3%
Q4 2018$864,00010,0670.18%
Other shareholders
NOVARTIS A G shareholders Q4 2019
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 146,405$11,768,0006.16%
MANAGED ASSET PORTFOLIOS, LLC 104,290$8,383,0005.88%
St. James Investment Company, LLC 645,032$51,848,0005.72%
NORTHROAD CAPITAL MANAGEMENT LLC 160,469$12,898,0004.62%
BROWN BROTHERS HARRIMAN & CO 12,336,767$991,629,0004.48%
Osher Van de Voorde Investment Management 83,754$6,732,0004.35%
SCHARF INVESTMENTS, LLC 1,185,951$95,327,0004.26%
Timber Creek Capital Management LLC 56,233$4,520,0004.22%
PROFESSIONAL ADVISORY SERVICES INC 200,030$16,078,0004.18%
Fayerweather Charles 14,565$1,171,0004.09%
View complete list of NOVARTIS A G shareholders